Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.
Leishmania donovani (LD), the causative agent of visceral leishmaniasis (VL), extracts membrane cholesterol from macrophages and disrupts lipid rafts, leading to their inability to stimulate T cells. Restoration of membrane cholesterol by liposomal delivery corrects the above defects and offers protection in infected hamsters. To reinforce further the protective role of cholesterol in VL, mice were either provided a high-cholesterol (atherogenic) diet or underwent statin treatment. Subsequent LD infection showed that an atherogenic diet is associated with protection, whereas hypocholesterolemia due to statin treatment confers susceptibility to the infection. This observation was validated in apolipoprotein E knockout mice (AE) mice that displayed intrinsic hypercholesterolemia with hepatic granuloma, production of host-protective cytokines, and expansion of antileishmanial CD8(+)IFN- γ (+) and CD8(+)IFN- γ (+)TNF- α (+) T cells in contrast to the wild-type C57BL/6 (BL/6) mice when infected with LD. Normal macrophages from AE mice (N-AE-MΦ) showed 3-fold higher membrane cholesterol coupled with increased fluorescence anisotropy (FA) compared with wild-type macrophage (N-BL/6-MΦ). Characterization of in vitro LD-infected AE macrophage (LD-AE-MΦ) revealed intact raft architecture and ability to stimulate T cells, which were compromised in LD-BL/6-MΦ. This study clearly indicates that hypercholesterolemia, induced intrinsically or extrinsically, can control the pathogenesis of VL by modulating immune repertoire in favor of the host.
Department of Infectious Diseases and Immunology, Indian Institute of Chemical Biology, Jadavpur, Kolkata-700032, India.
June
J
Ghosh
Shantanabha
S
Das
Rajan
R
Guha
Debopam
D
Ghosh
Kshudiram
K
Naskar
Anjan
A
Das
Syamal
S
Roy
D000818:Animals; D001057:Apolipoproteins E / Q000172:deficiency / Q000235:genetics; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism*; D002784:Cholesterol / Q000378:metabolism*; D016207:Cytokines / Q000276:immunology; D006099:Granuloma; D006949:Hyperlipidemias / Q000276:immunology / Q000378:metabolism* / Q000469:parasitology; D054992:Immunological Synapses / Q000276:immunology; D007893:Leishmania donovani / Q000276:immunology* / Q000472:pathogenicity; D007898:Leishmaniasis, Visceral / Q000276:immunology / Q000378:metabolism* / Q000469:parasitology / Q000517:prevention & control*; D008099:Liver / Q000473:pathology; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
D001057:Apolipoproteins E; D016207:Cytokines; D002784:Cholesterol